Todd Shriber

Todd Shriber

InvestorPlace Contributor

Recent Articles

The Risk-Reward Ratio of Ocugen Stock Is Positive

By Todd Shriber, InvestorPlace Contributor

OCGN stock isn't the next great biotech play, but savvy traders can limit its risk.

JETS ETF Still Fine for Investors That Can Handle Turbulence

By Todd Shriber, InvestorPlace Contributor

The JETS ETF is drawing a big crowd of investors this year and they could be handsomely rewarded if a Covid-19 vaccine comes to life.

Turn Out the Lights on iBio’s Covid-19 Vaccine Party

By Todd Shriber, InvestorPlace Contributor

IBIO stock is delivering heartache and more could be on the way as markets realize the company isn't going to deliver a Covid-19 vaccine.

7 Great Mutual Funds To Buy For Growth And Value

By Todd Shriber, InvestorPlace Contributor

Many of the leading mutual funds to buy in the current climate share one big thing in common: their exposure to growth stocks.

Jump for Jumia, Just Don’t Expect Amazon-esque Performance

By Todd Shriber, InvestorPlace Contributor

There's e-commerce opportunity in Africa and JMIA stock is one of the best ways to play that theme, but investors shouldn't expect miracles.

Load More